Abstract
Tissue homeostasis is maintained by tight control of signaling events that regulate cell death and cell survival. Apoptosis or programmed cell death plays a key role in maintaining tissue homeostasis under various conditions during normal development and in the adult organism. Thus, defective apoptosis programs contribute to the pathogenesis of various human diseases, for example to cancer formation. In addition, the antitumor activity of most cancer therapies, including chemotherapy, radiotherapy or immunotherapy, is mediated by the activation of apoptosis in cancer cells. Natural compounds including resveratrol have attracted much attention over the last decade both as cancer chemopreventive agents and as cancer therapeutics. To this end, resveratrol inhibits signal transduction pathways that block apoptosis and/or promote cell survival. Insights into the molecular mechanisms of how resveratrol regulates cell survival and cell death signaling is expected to open new avenues for the exploitation of resveratrol in the prevention and treatment of cancer.
Keywords: Apoptosis, resveratrol, cancer
Mini-Reviews in Organic Chemistry
Title: Regulation of Apoptosis and Cell Survival by Resveratrol
Volume: 7 Issue: 4
Author(s): Simone Fulda
Affiliation:
- Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstrasse 3a, 60528 Frankfurt am Main, Germany.,Germany
Keywords: Apoptosis, resveratrol, cancer
Abstract: Tissue homeostasis is maintained by tight control of signaling events that regulate cell death and cell survival. Apoptosis or programmed cell death plays a key role in maintaining tissue homeostasis under various conditions during normal development and in the adult organism. Thus, defective apoptosis programs contribute to the pathogenesis of various human diseases, for example to cancer formation. In addition, the antitumor activity of most cancer therapies, including chemotherapy, radiotherapy or immunotherapy, is mediated by the activation of apoptosis in cancer cells. Natural compounds including resveratrol have attracted much attention over the last decade both as cancer chemopreventive agents and as cancer therapeutics. To this end, resveratrol inhibits signal transduction pathways that block apoptosis and/or promote cell survival. Insights into the molecular mechanisms of how resveratrol regulates cell survival and cell death signaling is expected to open new avenues for the exploitation of resveratrol in the prevention and treatment of cancer.
Export Options
About this article
Cite this article as:
Fulda Simone, Regulation of Apoptosis and Cell Survival by Resveratrol, Mini-Reviews in Organic Chemistry 2010; 7(4) . https://dx.doi.org/10.2174/157019310792246355
DOI https://dx.doi.org/10.2174/157019310792246355 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Related Journals
Related Books

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers
Current Drug Targets Management of Endometrial Cancer: A Review
Reviews on Recent Clinical Trials The Battle of the Sexes for Stroke Therapy: Female- Versus Male-Derived Stem Cells
CNS & Neurological Disorders - Drug Targets Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway
Anti-Cancer Agents in Medicinal Chemistry Leptin, Estrogens and Cancer
Mini-Reviews in Medicinal Chemistry Role of Androgens in Womens Sexual Function & Dysfunction: What Have We Learned in Six Decades?
Current Women`s Health Reviews Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Current Pharmaceutical Design lGnRH-III - a Promising Candidate for Anticancer Drug Development
Protein & Peptide Letters Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Current Pharmaceutical Design Editorial [Hot Topic: The Therapeutic Potential of FOXO Proteins (Guest Editor: Wolfgang Link)]
Current Drug Targets Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets The Targets of Curcumin
Current Drug Targets The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Current Molecular Pharmacology CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Mini-Reviews in Medicinal Chemistry Recent Developments in Female Hormonal Contraception
Current Women`s Health Reviews Enzymatic regulation and functional relevance of NOX5
Current Pharmaceutical Design Antiangiogenic Therapy and Ovarian Cancer
Current Women`s Health Reviews Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets